![]() Negotiations with Moderna haven’t worked out and Johnson & Johnson received emergency authorization for use in August. Production of the Covaxin vaccine, developed by Indian company Bharat Biotech, did not accelerate as envisaged, at least in part due to quality issues of some batches. Supply situations continue to be challenging. 17, 2021 in a bid to achieve the 250 million target for August, although some projections consider it likely will be missed. A record 8.8 million doses were administered on Aug. With the vaccination campaign substantially picking up in India, about 15% of adults have now received both doses of the vaccine and nearly 40% a single dose. ![]() Habibur Rahman/Eyepix Group/Barcroft Media via Getty Images What’s the progress with vaccination? India stopped exporting oxygen to other countries after a severe shortage occurred during the first wave of COVID-19 cases fueled by the delta variant, which first appeared in India. Because the emerging threat was not recognized early enough, health care services were overwhelmed starting in early April, with the lack of reliable oxygen supply becoming a major problem. This wave was driven by multiple coronavirus variants, including alpha, which was first detected in the U.K., and delta, first identified in India and now the main source of infections in many countries. Alternative estimates have put excess deaths in the range of 3.4 million to 4.9 million. ![]() But this could be a dramatic under-counting. India emerged in June and July of 2021 from a particularly savage second wave of COVID-19, with total confirmed cases at about 32 million and more than 400,000 deaths. What explains the rapid spike and then sharp decline of cases of the April-to-June wave? You can see the whole collection of articles here. Here, Rajib Dasgupta from the Centre of Social Medicine and Community Health at Jawaharlal Nehru University in New Delhi writes about India following its devastating wave of infections earlier in 2021. To provide you with a global view as we approach a year and a half since the official declaration of the pandemic, The Conversation’s editors from around the world commissioned articles looking at specific countries and where they are now in combating the pandemic. Ms.Cases of COVID-19 are surging around the world, but the course of the pandemic varies widely country to country. ![]() Shambhavi Naik, Head of Research, Takshashila Institution K Chandrasekhar, Founder and CEO, Forus Health Keeping these in mind, the discussion will explore the potential for India and Israel to collaborate on digital health, with the aim of identifying actionable recommendations for policymakers and entrepreneurs. However, there are also challenges that need to be addressed, from the lack of capacity, concerns over privacy violations to the complexity of existing healthcare systems. The benefits of digital health have been evident throughout the COVID-19 pandemic. Moreover, services provided by digital health platforms need not be restricted to national boundaries. Already, there is greater availability of health-related information today, people’s access to doctors has improved significantly and real-time data monitoring is allowing better health outcomes. The advancement of digital technologies is set to revolutionise healthcare.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |